Evidence map›Paper›PMID 37158879›Full record

ArticleBMC biology2023

Secondary structure of the human mitochondrial genome affects formation of deletions.

Victor Shamanskiy, Alina A Mikhailova, Evgenii O Tretiakov, Kristina Ushakova, Alina G Mikhailova, Sergei Oreshkov, Dmitry A Knorre, Natalia Ree, Jonathan B Overdevest, Samuel W Lukowski and 13 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 9 countries.

Victor Shamanskiy *Center for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID http://orcid.org/0000-0001-7722-2232
Alina A Mikhailova *Center for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID http://orcid.org/0000-0002-6203-9977
Evgenii O Tretiakov *Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5920-2190
Kristina Ushakova *Center for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID http://orcid.org/0000-0002-6461-7777
Alina G Mikhailova *Center for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID https://orcid.org/0000-0002-5494-3536
Sergei OreshkovCenter for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID https://orcid.org/0000-0003-2030-5605
Dmitry A KnorreBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation.ORCID http://orcid.org/0000-0001-7468-6963
Natalia ReeCenter for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.
Jonathan B OverdevestDepartment of Otolaryngology, Columbia University Irving Medical Center, New York, USA.ORCID http://orcid.org/0000-0002-1152-2512
Samuel W LukowskiInstitute for Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia.ORCID http://orcid.org/0000-0002-8598-7902
Irina GostimskayaManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Valerian YurovCenter for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.
Chia-Wei LiouDepartment of Neurology, Kaohsiung Chang-Gung Memorial Hospital and Chang-Gung University, Kaohsiung, Taiwan.ORCID http://orcid.org/0000-0002-9003-4065
Tsu-Kung LinDepartment of Neurology, Kaohsiung Chang-Gung Memorial Hospital and Chang-Gung University, Kaohsiung, Taiwan.ORCID http://orcid.org/0000-0001-6656-1319
Wolfram S KunzDivision of Neurochemistry, Department of Experimental Epileptology and Cognition Research, University Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0003-1113-3493
Alexandre ReymondCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-1030-8327
Ilya MazuninCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia.ORCID http://orcid.org/0000-0002-5448-9679
Georgii A BazykinCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia.ORCID http://orcid.org/0000-0003-2334-2751
Jacques FellayEcole Polytechnique Federale de Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-8240-939X
Masashi TanakaDepartment for Health and Longevity Research, National Institutes of Biomedical Innovation, Health and Nutrition, 1-23-1 Toyama, Shinjuku-Ku, Tokyo, 162-8636, Japan.
Konstantin KhrapkoNortheastern University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9250-8033
Konstantin GunbinCenter for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.ORCID http://orcid.org/0000-0003-1851-8169
Konstantin PopadinCenter for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia. konstantin.popadin@epfl.ch.ORCID http://orcid.org/0000-0002-2117-6086
Immanuel Kant Baltic Federal University · RUChang Gung University · TWSIB Swiss Institute of Bioinformatics · CHSkolkovo Institute of Science and Technology · RUColumbia University Irving Medical Center · USÉcole Polytechnique Fédérale de Lausanne · CHJuntendo University · JPLomonosov Moscow State University · RUMedical University of Vienna · ATNortheastern University · USThe University of Queensland · AUUniversity of Bonn · DEUniversity of Cambridge · GB

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19K23DC019678 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OVERDEVEST, JONATHAN B · 2021 to 2025
$893k
Austrian Science Fund FWF DOC 33NCATS NIH HHS UL1 TR001873NIDCD NIH HHS K23 DC019678
6 · The paper itself

Abstract

backgroundAging in postmitotic tissues is associated with clonal expansion of somatic mitochondrial deletions, the origin of which is not well understood. Such deletions are often flanked by direct nucleotide repeats, but this alone does not fully explain their distribution. Here, we hypothesized that the close proximity of direct repeats on single-stranded mitochondrial DNA (mtDNA) might play a role in the formation of deletions.

resultsBy analyzing human mtDNA deletions in the major arc of mtDNA, which is single-stranded during replication and is characterized by a high number of deletions, we found a non-uniform distribution with a "hot spot" where one deletion breakpoint occurred within the region of 6-9 kb and another within 13-16 kb of the mtDNA. This distribution was not explained by the presence of direct repeats, suggesting that other factors, such as the spatial proximity of these two regions, can be the cause. In silico analyses revealed that the single-stranded major arc may be organized as a large-scale hairpin-like loop with a center close to 11 kb and contacting regions between 6-9 kb and 13-16 kb, which would explain the high deletion activity in this contact zone. The direct repeats located within the contact zone, such as the well-known common repeat with a first arm at 8470-8482 bp (base pair) and a second arm at 13,447-13,459 bp, are three times more likely to cause deletions compared to direct repeats located outside of the contact zone. A comparison of age- and disease-associated deletions demonstrated that the contact zone plays a crucial role in explaining the age-associated deletions, emphasizing its importance in the rate of healthy aging.

conclusionsOverall, we provide topological insights into the mechanism of age-associated deletion formation in human mtDNA, which could be used to predict somatic deletion burden and maximum lifespan in different human haplogroups and mammalian species.

Indexed as

Genome, MitochondrialAnimalsDNA, MitochondrialDNA, Single-StrandedGenome, HumanHumansMammalsMitochondriaProtein Structure, SecondaryDNA, MitochondrialDNA, Single-StrandedAgingContact zoneDeletionsDirect repeatsGlobal secondary structureInverted repeatsMitochondrial DNAmtDNA replicationSingle-stranded DNA

Identifiers

PMID37158879
PMCPMC10166460
OpenAlexW4375858507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.